[artículo] 
inThe Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No. 5 (Septiembre - Octubre) . - pp. 6-13

Título :	Real-World Outcomes in the Management of Refractory Psychosis
Tipo de documento:	texto impreso
Autores:	Amir Krivoy, Autor ; Dan Joyce, Autor
Fecha de publicación:	2019
Artículo en la página:	pp. 6-13
Idioma :	Inglés (eng)
Palabras clave:	Psicosis refractaria, Clozapina.
Resumen:	Clozapine is the only medication approved for those patients with schizophrenia who do not achieve a clinical response to standard antipsychotic treatment, yet it is still underused. Furthermore, in the case of a partial or minimal response to clozapine treatment, there is no clarity on the next pharmacologic intervention.
Link:	./index.php?lvl=notice_display&id=21309

[artículo] Real-World Outcomes in the Management of Refractory Psychosis [texto impreso] / Amir Krivoy, Autor ; Dan Joyce, Autor . - 2019 . - pp. 6-13.
Idioma : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No. 5 (Septiembre - Octubre) . - pp. 6-13

Palabras clave:	Psicosis refractaria, Clozapina.
Resumen:	Clozapine is the only medication approved for those patients with schizophrenia who do not achieve a clinical response to standard antipsychotic treatment, yet it is still underused. Furthermore, in the case of a partial or minimal response to clozapine treatment, there is no clarity on the next pharmacologic intervention.
Link:	./index.php?lvl=notice_display&id=21309